These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 21118397

  • 1. The efficacy of shortening the dosing interval to once every six weeks in Crohn's patients losing response to maintenance dose of infliximab.
    Kopylov U, Mantzaris GJ, Katsanos KH, Reenaers C, Ellul P, Rahier JF, Israeli E, Lakatos PL, Fiorino G, Cesarini M, Tsianos EV, Louis E, Ben-Horin S.
    Aliment Pharmacol Ther; 2011 Feb; 33(3):349-57. PubMed ID: 21118397
    [Abstract] [Full Text] [Related]

  • 2. Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children.
    Hyams J, Crandall W, Kugathasan S, Griffiths A, Olson A, Johanns J, Liu G, Travers S, Heuschkel R, Markowitz J, Cohen S, Winter H, Veereman-Wauters G, Ferry G, Baldassano R, REACH Study Group.
    Gastroenterology; 2007 Mar; 132(3):863-73; quiz 1165-6. PubMed ID: 17324398
    [Abstract] [Full Text] [Related]

  • 3. Long-term durability of infliximab treatment in Crohn's disease and efficacy of dose "escalation" in patients losing response.
    Chaparro M, Panes J, García V, Mañosa M, Esteve M, Merino O, Andreu M, Gutierrez A, Gomollón F, Cabriada JL, Montoro MA, Mendoza JL, Nos P, Gisbert JP.
    J Clin Gastroenterol; 2011 Feb; 45(2):113-8. PubMed ID: 21242747
    [Abstract] [Full Text] [Related]

  • 4. Loss of response and requirement of infliximab dose intensification in Crohn's disease: a review.
    Gisbert JP, Panés J.
    Am J Gastroenterol; 2009 Mar; 104(3):760-7. PubMed ID: 19174781
    [Abstract] [Full Text] [Related]

  • 5. Infliximab in the treatment of Crohn's disease: a user's guide for clinicians.
    Sandborn WJ, Hanauer SB.
    Am J Gastroenterol; 2002 Dec; 97(12):2962-72. PubMed ID: 12492177
    [Abstract] [Full Text] [Related]

  • 6. Infliximab treatment for symptomatic Crohn's disease strictures.
    Pelletier AL, Kalisazan B, Wienckiewicz J, Bouarioua N, Soulé JC.
    Aliment Pharmacol Ther; 2009 Feb 01; 29(3):279-85. PubMed ID: 19035967
    [Abstract] [Full Text] [Related]

  • 7. Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: a pilot study.
    Asteria CR, Ficari F, Bagnoli S, Milla M, Tonelli F.
    Scand J Gastroenterol; 2006 Sep 01; 41(9):1064-72. PubMed ID: 16938720
    [Abstract] [Full Text] [Related]

  • 8. Infliximab dependency is related to decreased surgical rates in adult Crohn's disease patients.
    Pedersen N, Duricova D, Lenicek M, Elkjaer M, Bortlik M, Andersen PS, Vitek L, Davidsen B, Wewer V, Lukas M, Munkholm P.
    Eur J Gastroenterol Hepatol; 2010 Oct 01; 22(10):1196-203. PubMed ID: 20739896
    [Abstract] [Full Text] [Related]

  • 9. Increasing the infliximab dose is beneficial in Crohn's disease patients who responded to a lower dose and relapsed.
    Menachem Y, Avidan B, Lavy A, Lang A, Bardan E, Fidder H, Bar-Meir S, Chowers Y.
    Digestion; 2005 Oct 01; 72(2-3):124-8. PubMed ID: 16172549
    [Abstract] [Full Text] [Related]

  • 10. [Treatment of Crohn's disease by infliximab. About 20 cases].
    Serghini M, Karoui S, Meknini M, Matri S, Kallel L, Fekih M, Boubaker J, Filali A.
    Tunis Med; 2009 Sep 01; 87(9):579-82. PubMed ID: 20180377
    [Abstract] [Full Text] [Related]

  • 11. Prolonged duration of response to infliximab in early but not late pediatric Crohn's disease.
    Kugathasan S, Werlin SL, Martinez A, Rivera MT, Heikenen JB, Binion DG.
    Am J Gastroenterol; 2000 Nov 01; 95(11):3189-94. PubMed ID: 11095340
    [Abstract] [Full Text] [Related]

  • 12. Management of Crohn's disease of the ileoanal pouch with infliximab.
    Colombel JF, Ricart E, Loftus EV, Tremaine WJ, Young-Fadok T, Dozois EJ, Wolff BG, Devine R, Pemberton JH, Sandborn WJ.
    Am J Gastroenterol; 2003 Oct 01; 98(10):2239-44. PubMed ID: 14572574
    [Abstract] [Full Text] [Related]

  • 13. Clinical advantages of combined seton placement and infliximab maintenance therapy for perianal fistulizing Crohn's disease: when and how were the seton drains removed?
    Tanaka S, Matsuo K, Sasaki T, Nakano M, Sakai K, Beppu R, Yamashita Y, Maeda K, Aoyagi K.
    Hepatogastroenterology; 2010 Oct 01; 57(97):3-7. PubMed ID: 20422862
    [Abstract] [Full Text] [Related]

  • 14. Infliximab dependency in children with Crohn's disease.
    Duricova D, Pedersen N, Lenicek M, Hradsky O, Bronsky J, Adamcova M, Elkjaer M, Andersen PS, Vitek L, Larsen K, Lukas M, Nevoral J, Wewer V, Munkholm P.
    Aliment Pharmacol Ther; 2009 Apr 01; 29(7):792-9. PubMed ID: 19183163
    [Abstract] [Full Text] [Related]

  • 15. Infliximab improves inflammation and anthropometric measures in pediatric Crohn's disease.
    Sinitsky DM, Lemberg DA, Leach ST, Bohane TD, Jackson R, Day AS.
    J Gastroenterol Hepatol; 2010 Apr 01; 25(4):810-6. PubMed ID: 20492339
    [Abstract] [Full Text] [Related]

  • 16. [Indications and results of infliximab in Crohn's disease].
    Karoui S, Boubaker J, Filali A.
    Tunis Med; 2004 Dec 01; 82(12):1057-63. PubMed ID: 15822505
    [Abstract] [Full Text] [Related]

  • 17. [Treatment of Crohn's disease with anti-TNF alpha antibodies (infliximab): results of a multicentric and retrospective study].
    Doubremelle M, Bourreille A, Zerbib F, Heresbach D, Metman EH, Beau P, Gournay J, Galmiche JP.
    Gastroenterol Clin Biol; 2002 Nov 01; 26(11):973-9. PubMed ID: 12483127
    [Abstract] [Full Text] [Related]

  • 18. Infliximab: lifetime use for maintenance is appropriate in Crohn's Disease. A BALANCING VIEW: lifetime channeling of infliximab for crohn's disease.
    Hanauer SB.
    Am J Gastroenterol; 2005 Jul 01; 100(7):1438-9. PubMed ID: 15984961
    [No Abstract] [Full Text] [Related]

  • 19. Withdrawal of immunosuppression in Crohn's disease treated with scheduled infliximab maintenance.
    Francis G, Duggan A.
    Gastroenterology; 2008 Dec 01; 135(6):2156-7. PubMed ID: 19013168
    [No Abstract] [Full Text] [Related]

  • 20. Infliximab for Crohn's disease in clinical practice: the experience of a single center in romania.
    Gheorghe L, Gheorghe C, Badea M, Vădan R, Pârvulescu I, Toader C, Tugui L, Papuc O, Ionescu R, Preda C, Călin I, Diculescu M.
    Rom J Gastroenterol; 2003 Mar 01; 12(1):7-13. PubMed ID: 12673373
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.